Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2009 Jun;8(6):465-79.
doi: 10.1038/nrd2783.

Unleashing the therapeutic potential of NOD-like receptors

Kaoru Geddes  1 , João G Magalhães, Stephen E Girardin
Affiliations
Review

Unleashing the therapeutic potential of NOD-like receptors

Kaoru Geddes et al. Nat Rev Drug Discov. 2009 Jun.

Abstract

Nucleotide-binding and oligomerization domain (NOD)-like receptors (NLRs) are a family of intracellular sensors that have key roles in innate immunity and inflammation. Whereas some NLRs - including NOD1, NOD2, NAIP (NLR family, apoptosis inhibitory protein) and NLRC4 - detect conserved bacterial molecular signatures within the host cytosol, other members of this family sense 'danger signals', that is, xenocompounds or molecules that when recognized alert the immune system of hazardous environments, perhaps independently of a microbial trigger. In the past few years, remarkable progress has been made towards deciphering the role and the biology of NLRs, which has shown that these innate immune sensors have pivotal roles in providing immunity to infection, adjuvanticity and inflammation. Furthermore, several inflammatory disorders have been associated with mutations in human NLRgenes. Here, we discuss the effect that research on NLRs will have on vaccination, treatment of chronic inflammatory disorders and acute bacterial infections.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Respirology. 2008 Jun;13(4):488-97 - PubMed
    1. PLoS One. 2008 Jul 23;3(7):e2769 - PubMed
    1. J Exp Med. 1984 Jan 1;159(1):68-76 - PubMed
    1. Nat Immunol. 2003 Jul;4(7):702-7 - PubMed
    1. J Antibiot (Tokyo). 1992 Feb;45(2):258-64 - PubMed

MeSH terms

LinkOut - more resources